Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen Meeting Abstract
| Authors: | Shen, S.; Myers, S.; Polidorio, N.; Bromberg, M.; Chen, Y.; Tan, R.; Mai, N.; Abuhadra, N.; Traina, T. A.; Downs-Canner, S.; Iyengar, N. M. |
| Abstract Title: | Timing of neoadjuvant pembrolizumab infusion and pathologic complete response among patients with triple-negative breast cancer receiving the KEYNOTE-522 regimen |
| Meeting Title: | 2025 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2025 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-06-01 |
| Start Page: | e12616 |
| Language: | English |
| ACCESSION: | WOS:001509250400001 |
| DOI: | 10.1200/JCO.2025.43.16_suppl.e12616 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
